Predonation screening of candidate donors and prevention of window period donations

Transfusion

Volumn 55, Issue 2, 2015, Pages 373-378

  Lieshout Krikke, Ryanne W ^a   Zaaijer, Hans L ^a   Van De Laar, Thijs J W ^a  

^a CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD EXAMINATION; BLOOD SAFETY; BLOOD SAMPLING; BLOOD TRANSFUSION; CLINICAL ARTICLE; DISEASE TRANSMISSION; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MALE; NETHERLANDS; SCREENING TEST; SEROCONVERSION; SEROLOGY; BLOOD; DONOR SELECTION; HEPACIVIRUS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; INCIDENCE; PROCEDURES; RETROSPECTIVE STUDY; TIME; TRANSMISSION;

ADULT; BLOOD DONORS; DONOR SELECTION; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; MALE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84923068754     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12809     Document Type: Article

References (21)

1. Dwyre DM, Fernando LP, Holland PV,. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sang 2011; 100: 92-98.
2. Stramer SL, Wend U, Candotti D, et al. Nucleic acid testing to detect HBV infection in donors. N Engl J Med 2011; 364: 236-247.
3. González R, Echevarria LM, Avellón A, et al. Acute hepatitis B virus window period blood donations detected by individual donation nucleic acid testing: a report of the first two case found and interdicted in Spain. Transfusion 2006; 46: 1138-1142.
4. Delwart EL, Kalmin ND, Jones TS, et al. First report of human immunodeficiency virus transmission via an RNA-screened blood donation. Vox Sang 2004; 86: 171-177.
5. Laffoon B, Crutchfield A, Levi M, et al. HIV transmission through transfusion - Missouri and Colorado 2008. MMWR Morb Mortal Wkly Rep 2010; 59: 1335-1339.
6. th) [cited 3 June 2014]. Available from: http://www.japantimes.co.jp/news/2013/11/26/national/blood-of-hiv-infected-man-used-in-transfusions-source
7. Zou S, Fujii K, Johnson S, et al.; ARCNET Study Group. Prevalence of selected viral infections among blood donors deferred for potential risk to blood safety. Transfusion 2006; 46: 1997-2003.
8. Van der Bij AK, Coutinho RA, Van der Poel CL,. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands. Transfusion 2006; 46: 1729-1736.
9. Delwart E, Silkas E, Stramer SL, et al. for the NHLBI-REDS-II Study Group. Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors. J Infect Dis 2012; 205: 875-885.
10. Roth WK, Busch MP, Schuller A, et al. International survey on NAT testing of blood donations: expanding implementation and the yield from 1999 to 2009. Vox Sang 2012; 102: 82-90.
11. Rosenberg GK, Lattimor S, Brailsford SR, et al. Acute hepatitis B in blood donors over a 5 year period in England and North Wales: who is getting infected? Transfusion 2013; 53: 2467-2476.
12. Damesyn MA, Glynn SA, Schreiber GB, et al.; NHLBI Retrovirus Epidemiology Donor Study. Behavioral and infectious diseases risks in young blood donors: implications for recruitment. Transfusion 2003; 43: 1596-1603.
13. Trienekens SC, van den Broek IV, Donker GA, et al. Consultations for sexually transmitted infections in the general practice in the Netherlands: an opportunity to improve STI/HIV testing. BMJ Open 2013; 3: e003687.
14. O'Brien SF, Yi QL, Fan W, et al. Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay. Transfusion 2009; 49: 271-277.
15. Notari EP, Zou S, Fang CT, et al. Age-related donor return patterns among first-time blood donors in the United States. Transfusion 2009; 49: 2229-2236.
16. Koedijk FD, van der Sande MA, Hahné SJ,. Incidentie van meldingen van acute hepatitis B in 2011 lager dan ooit. Infectieziekten Bull 2013; 24: 112-116 [in Dutch].
17. Whelan J, Sonder G, Heuker J, et al. Incidence of acute hepatitis B in different ethnic groups in a low-endemic country, 1992-2009: increased risk in second generation migrants. Vaccine 2012; 30: 5651-5655.
18. Van Houdt R, Koedijk FD, Bruisten SM, et al. Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: does it work? Vaccine 2009; 27: 3530-3535.
19. Bruhn R, Lelie N, Custer B, et al.; International NAT Study Group. Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios. Transfusion 2013; 53: 2399-2412.
20. De Vos AS, van de Helm JJ, Matser A, et al. Decline in the incidence of HIV and hepatitis C infection among injecting drug users in Amsterdam: evidence for harm reduction. Addiction 2013; 108: 1070-1081.
21. HIV Monitoring Foundation. Monitoring report 2013: Human Immunodeficiency virus (HIV) infections in the Netherlands. 2013 [cited 3 June 2014]. Available from: http://www.hiv-monitoring.nl